David P.
King currently works at Fortis Life Sciences LLC, as Chairman & Chief Executive Officer, Program for Appropriate Technology in Health, as Vice Chairman, ScribeAmerica, Inc., as Executive Chairman from 2021, Privia Health Group, Inc., as Non-Executive Chairman from 2021, Smith & Nephew plc, as Independent Non-Executive Director from 2025, binx health, inc., as Director from 2021, Personalized Medicine Coalition, as Director, BioAgilytix Labs LLC, as Director from 2022, Emily Krzyzewski Family Life Center, Inc., as Director from 2018, Seattle Science Foundation, as Director, Binx Health Ltd., as Director from 2021, Durham Academy, Inc., as Trustee, Healthquest Capital Management Co LLC, as Operating Partner from 2023, Kingman LLC, as Managing Member from 2020, and Novant Health, Inc., as Trustee from 2021.
Mr. King also formerly worked at Laboratory Corp.
of America Holdings, as Chairman from 2019 to 2020, American Clinical Laboratory Association, as Chairman from 2010 to 2014, The Health Channel, Inc., as Executive Chairman, ZimVie, Inc., as Non-Executive Chairman from 2022 to 2025, VaxCare Corp., as Director from 2021 to 2025, Cardinal Health, Inc., as Independent Director from 2011 to 2018, CancerGuide Diagnostics, Inc., as Director, PATH, Inc., as Director, Hogan & Hartson LLP, as Partner in 2001, US Pathology Labs, Inc., as President, Elon University, as Trustee, and PPC Investment Partners LP, as Operating Partner from 2020 to 2021.
Mr. King received his undergraduate degree from Princeton University and graduate degree in 1985 from The University of Pennsylvania Law School.